Logo image of VRDN

VIRIDIAN THERAPEUTICS INC (VRDN) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:VRDN - US92790C1045 - Common Stock

32.57 USD
-0.69 (-2.07%)
Last: 1/20/2026, 3:18:04 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
VRDN revenue by date.VRDN revenue by date.
1.77M
-40.20%
314K
-82.26%
302K
-3.82%
79.6M
26,257.62%
83.213M
4.54%
320.15M
284.74%
690.05M
115.54%
1.009B
46.22%
1.352B
33.99%
1.628B
20.41%
2.002B
22.97%
1.719B
-14.14%
EBITDA
YoY % growth
VRDN ebitda by date.VRDN ebitda by date.
-134.04M
-68.37%
-253.928M
-89.44%
-298.495M
-17.55%
-316.029M
-5.87%
-350.55M
-10.92%
-179.197M
48.88%
449.86M
351.04%
837.83M
86.24%
1.1B
31.29%
1.335B
21.36%
1.363B
2.10%
N/A
EBIT
YoY % growth
VRDN ebit by date.VRDN ebit by date.
-134.3M
-68.44%
-254.45M
-89.46%
-299.035M
-17.52%
-351.443M
-17.53%
-399.087M
-13.56%
-223.863M
43.91%
92.48M
141.31%
375.27M
305.79%
580.88M
54.79%
750.7M
29.23%
950M
26.55%
843.53M
-11.21%
Operating Margin
VRDN operating margin by date.VRDN operating margin by date.
-7,587.57%-81,035.03%-99,018.21%-441.51%-479.60%-69.92%13.40%37.19%42.96%46.11%47.45%49.07%
EPS
YoY % growth
VRDN eps by date.VRDN eps by date.
-4.03
47.59%
-5.32
-32.01%
-3.96
25.56%
-4.23
-6.82%
-3.78
10.56%
-1.96
48.27%
0.36
118.33%
2.80
679.90%
4.50
60.84%
5.80
28.88%
7.03
21.26%
7.06
0.41%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-1.10
-9.97%
-1.15
-31.99%
-1.08
-7.53%
-0.89
-163.05%
-0.95
13.82%
-0.69
39.60%
-0.61
43.08%
-0.52
41.84%
-0.31
67.71%
Revenue
Q2Q % growth
12.986M
17,936.11%
20.4K
-71.67%
25.52M
33,926.67%
27.149M
-61.53%
34.419M
165.05%
42.126M
206,400.00%
54.978M
115.43%
68.544M
152.47%
97.726M
183.93%
EBITDA
Q2Q % growth
-76.631M
11.85%
-101.622M
-8.40%
-69.513M
34.75%
-104.935M
-164.50%
-98.564M
-28.62%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-100.558M
-14.96%
-111.663M
-18.96%
-82.113M
23.09%
-88.18M
-120.38%
-91.744M
8.76%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.34
70.43%
-1.100.7669.21%
Q2 2025
Q2Q % growth
-1.00
1.96%
-1.030.032.88%
Q1 2025
Q2Q % growth
-0.87
-10.13%
-0.990.1211.80%
Q4 2024
Q2Q % growth
-1.00
25.93%
-1.060.065.31%
Q3 2024
Q2Q % growth
-1.15
-5.50%
-1.08-0.07-6.60%
Q2 2024
Q2Q % growth
-1.02
19.69%
-0.91-0.11-12.54%
Q1 2024
Q2Q % growth
-0.79
50.93%
-1.130.3429.83%
Q4 2023
Q2Q % growth
-1.35
-19.47%
-1.02-0.33-31.95%
Q3 2023
Q2Q % growth
-1.09
-26.74%
-1.290.2015.60%
Q2 2023
Q2Q % growth
-1.27
-19.81%
-1.320.053.82%
Q1 2023
Q2Q % growth
-1.61
-64.29%
-1.04-0.57-54.81%
Q4 2022
Q2Q % growth
-1.13
14.39%
-0.74-0.39-52.18%
Q3 2022
Q2Q % growth
-0.86
31.20%
-1.040.1817.11%
Q2 2022
Q2Q % growth
-1.06
52.04%
-0.92-0.14-14.92%
Q1 2022
Q2Q % growth
-0.98
66.32%
-1.100.1210.71%
Q4 2021
Q2Q % growth
-1.32
75.14%
-0.92-0.40-44.25%
Q3 2021
Q2Q % growth
-1.25
16.67%
-1.500.2516.82%
Q2 2021
Q2Q % growth
-2.21
-22.78%
-1.55-0.66-42.73%
Q1 2021
Q2Q % growth
-2.91
-7.78%
-0.77-2.14-277.37%
Q4 2020
Q2Q % growth
-5.31 -0.63-4.68-748.79%
Q3 2020
Q2Q % growth
-1.50 -2.030.5326.01%
Q2 2020
Q2Q % growth
-1.80 -2.520.7228.70%
Q1 2020
Q2Q % growth
-2.70 -2.940.248.09%
VRDN Yearly EPS VS EstimatesVRDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -100 -200 -300
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
70.57M
81,958.14%
34.588K70.535M203,929.12%
Q2 2025
Q2Q % growth
75K
4.17%
44.513K30.487K68.49%
Q1 2025
Q2Q % growth
72K 71.533K467.39999999999420.65%
Q4 2024
Q2Q % growth
72K 45.39K26.61K58.63%
Q3 2024
Q2Q % growth
86K
19.44%
46.685K39.315K84.21%
Q2 2024
Q2Q % growth
72K 87.873K-15.873K-18.06%
Q1 2024
Q2Q % growth
72K
-26.53%
72.604K-603.6000000000058-0.83%
Q4 2023
Q2Q % growth
72K
-34.55%
162.792K-90.792K-55.77%
Q3 2023
Q2Q % growth
72K
-94.00%
112.853K-40.853K-36.20%
Q2 2023
Q2Q % growth
72K
-72.31%
220.493K-148.493K-67.35%
Q1 2023
Q2Q % growth
98K
-55.45%
113.444K-15.444K-13.61%
Q4 2022
Q2Q % growth
110K
-47.62%
522.118K-412.118K-78.93%
Q3 2022
Q2Q % growth
1.2M
471.43%
315.517K884.483K280.33%
Q2 2022
Q2Q % growth
260K
-76.15%
236.344K23.656K10.01%
Q1 2022
Q2Q % growth
220K
-84.83%
310.284K-90.284K-29.10%
Q4 2021
Q2Q % growth
210K
320.00%
291.383K-81.383K-27.93%
Q3 2021
Q2Q % growth
210K 463.284K-253.284K-54.67%
Q2 2021
Q2Q % growth
1.09M
541.18%
1.09M%
Q1 2021
Q2Q % growth
1.45M
74.70%
1.45M%
Q4 2020
Q2Q % growth
50K 81.6K-31.6K-38.73%
Q3 2020
Q2Q % growth
157.59K-157.59K-100.00%
Q2 2020
Q2Q % growth
170K 532.236K-362.236K-68.06%
Q1 2020
Q2Q % growth
830K 594.15K235.85K39.70%
VRDN Yearly Revenue VS EstimatesVRDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.99% 2.65% -2.02% 1.77%
Revenue-7.69% 26341.1% -0.83% 52275.3%